Skip to main content

UCS Investment 2016 In Review


2016 was a tough year. There were 3 main drivers that I believe contributed to the high volatility in the stock market this year, 'political uncertainty', 'Dow Jones volatility' and the 'tepid economic recovery.

Political uncertainty
It was a tough year to make consistent profits using our index-based approach to investing (but we did anyway) because rather than moving in-line with earnings announcements, markets moved lockstep with political events such as the continuing 'War on Terror', Brexit and the U.S. election.

Dow gains
Just because the Dow Jones Industrial Average made new highs this year does not mean that your should just as high also.  The DJIN index is made up of selected stocks based on their market capitalization. The index may slightly over-represent the health or the strength of the economy.  I think a better indicator of the strength and health of the economy are the earnings from companies that make up the S&P 500. The fact that many investors buy stocks based on different investment strategies which does not include Dow stocks suggest that any movements in the Dow, whether up or down, may not affect your investments. 

Tepid recovery
Finally, I was expecting a robust economic recovery but that did not materialize even though job growth picked-up in the third quarter of this year. Many companies still did not hire and instead laid off employees i.e.. ATT layoffs. Not even the best productivity software could bridge the gap between 2016 business friendly federal economic policies and the fear of another recession.

I look forward to a better year in 2017.  However, I think this year will also be politically driven. For example, The Jobs Act of 2015 and The Cures Act of 2016 will make a huge difference for many businesses and individuals next year in the biotechnology and pharmaceutical industry.  I believe both bills will be strong drivers of the economy in 2017 and beyond.

Thank you for joining UCS Investment Co and have a great 2017!


Brought to you by: ThrushyMedia

Comments

Popular posts from this blog

Morning Update

By Rick Walter Still working on putting together a strong biotech portfolio. Here is a good general article on the state of the biotech industry that was posted yesterday on the online Wall Street Journal's site- Biotech Stocks Hot Right Now, Ho-Hum in the Long Run.

Portfolio Update

By Rick Walter I have posted a new Biotechnology portfolio . It's total return as of November 25, 2009 is 3.4%. However, to download and use it you will have to subscribe to the portfolio, of course. On an important note, I consider each portfolio to be well diversified in its particular sector but I've recently decided to add stock futures and options positions to each portfolio which will increase each portfolio's return but lower the risks going forward.

Whose lending?

Troubled times ahead for everyone it seems. Credit markets still seems to be troubled. The Federal Reserve stands willing to provide liquidity to the markets although modestly. If I was running a pretty profitable business and I needed capital now, could I rely on my existing banking relationship to provide me the capital now? Here is an article in the WSJ on "Prior Loans, Future Pain?" Link . This article is free, no subscription needed . I guess the answer might be how much you need and the terms, but wouldn't you feel slighted if you had a banking relationship with your banker for lets say 10 years and you asked your banker to increase your credit line by about an additional 40% and they said no. In this scenario, with all things being equal, of good personal credit and business scores, pretty robust industry growth projections, and business debt to credit ratio of 1.20 or better. What would be the reason(s) for a bank decline? I called and left a message to a banker...